Periscope Capital’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,141
Closed -$119K 914
2021
Q2
$119K Buy
+12,141
New +$118K ﹤0.01% 675

Other funds holding GRNA

Periscope Capital's GRNA Position: Q3 2021 in Review

Periscope Capital sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2021, closing a stake of 12,141 shares — an estimated $119K sold.

Periscope Capital first reported a position in GRNA in Q2 2021 and held it in 1 quarter. The position peaked at $119K in Q2 2021. 70 funds tracked by Wall St. Rank hold GRNA as of Q3 2021.

  • Periscope Capital reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2021 after selling out during the quarter.
  • Periscope Capital sold 12,141 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2021, an estimated $119K.
  • Periscope Capital first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2021 and held it in 1 quarter.
  • Periscope Capital's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $119K in Q2 2021.
  • 70 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2021.

Based on Periscope Capital's 13F filing for Q3 2021, filed 12 Nov 2021.